HMG-COA reductase inhibitor metabolites

Details HMG-COA reductase inhibitor metabolites HMG-COA reductase inhibitor metabolites

1992-02-18

1995-01-31

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

549292, A61K 31365

Patent

active

053859324

ABSTRACT:
This invention relates to compounds of formulae I and II ##STR1## which are metabolites of tetrahydrosimvastatin and 5-hydroxy-tetrahydrosimvastatin and which are HMG--CoA reductase inhibitors.

REFERENCES:
patent: 4517373 (1985-05-01), Terahara et al.
patent: 4537859 (1985-08-01), Terahara et al.
patent: 4584389 (1986-04-01), Sletzinger et al.
patent: 4604472 (1986-08-01), Ide et al.
patent: 4733003 (1988-03-01), Ide et al.
patent: 4833258 (1989-05-01), Smith et al.
patent: 4897402 (1990-01-01), Duggan et al.
patent: 4921974 (1990-05-01), Duggan et al.
patent: 4940727 (1990-07-01), Inamine et al.
patent: 4963538 (1990-10-01), Duggan et al.
patent: 5073568 (1991-12-01), Wovkulich et al.
patent: 5173487 (1992-12-01), Saunders et al.
Terahara et al. "MB 530B Derivatives and their Pharmaceutical Compositions" CA 99: 70288t (1983).

Affiliated with

Also associated with

Rating

HMG-COA reductase inhibitor metabolites does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HMG-COA reductase inhibitor metabolites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HMG-COA reductase inhibitor metabolites will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1102494